医学
养生
甲氧苄啶
环丙沙星
磺胺甲恶唑
内科学
外科
随机对照试验
安慰剂
抗生素
生物
替代医学
病理
微生物学
作者
David A. Talan,Walter E. Stamm,Thomas M. Hooton,Gregory J. Moran,Thomas F. Burke,Abdollah Iravani,Jonathan Reuning‐Scherer,Deborah Church
出处
期刊:JAMA
[American Medical Association]
日期:2000-03-22
卷期号:283 (12): 1583-1583
被引量:463
标识
DOI:10.1001/jama.283.12.1583
摘要
UNITED STATES AT LEAST 250 000 episodes of acute pyelonephritis occur annually among adult women, resulting in as many as 100 000 hospitalizations. 1,2However, the optimal antimicrobial regimen and duration of therapy for this infection have not been established.4][5] Three-day regimens of trimethoprim-sulfamethoxazole or fluoroquinolones appear to provide adequate cure rates, while being associated with lower cost and fewer adverse effects than longer regimens.The current standard duration of therapy for acute uncomplicated pyelonephritis is 14 days, but few studies of shorter-course therapy for this infection have been undertaken.Increasing antimicrobial re-
科研通智能强力驱动
Strongly Powered by AbleSci AI